<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Child Health</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/483D5886-D9B1-46DB-87FB-A90770EBBAA1"><gtr:id>483D5886-D9B1-46DB-87FB-A90770EBBAA1</gtr:id><gtr:firstName>Francesco</gtr:firstName><gtr:surname>Muntoni</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/65EB5007-A4FD-493B-8EA3-3B18BA240012"><gtr:id>65EB5007-A4FD-493B-8EA3-3B18BA240012</gtr:id><gtr:firstName>Jennifer</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Morgan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/06E9C900-A07E-4D04-A0C3-0DF79EA9BB4E"><gtr:id>06E9C900-A07E-4D04-A0C3-0DF79EA9BB4E</gtr:id><gtr:firstName>HKM</gtr:firstName><gtr:surname>Lochmuller</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B0FFB06E-0C80-4114-9D30-7040F66F445B"><gtr:id>B0FFB06E-0C80-4114-9D30-7040F66F445B</gtr:id><gtr:firstName>Adrian</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Thrasher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C57B635D-F825-4AA3-B68D-BD6AC10FF6ED"><gtr:id>C57B635D-F825-4AA3-B68D-BD6AC10FF6ED</gtr:id><gtr:firstName>Olivier</gtr:firstName><gtr:surname>Danos</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900872"><gtr:id>E10D49BB-10BC-4990-B744-9448E90E8CB3</gtr:id><gtr:title>Lentivirally-mediated stem cells to treat Duchenne muscular dystrophy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900872</gtr:grantReference><gtr:abstractText>Duchenne muscular dystrophy (DMD) is an X-linked condition in which muscle fibres degenerate due to the lack of the protein dystrophin. Stem cells, called satellite cells, within skeletal muscle do repair and regenerate lost fibres, but as the new fibres remain dystrophin-deficient, they continually break down, eventually leading to loss of muscle fibres and replacement by fat and connective tissue. If we want to use stem cells to treat DMD, these would have to be a type of stem cell that can be delivered via the blood system, as DMD affects all the muscles of the body. We propose to use stem cells derived from the patient themselves, so that they would not promote immunonological rejection. We aim to engineer these stem cells so that they have a heritable copy of the dystrophin gene. But the whole dystrophin gene is too large to fit into any viral vector. We will therefore engineer the dystrophin gene to be small enough to fit into a lentiviral vector, but large enough to contain as much as possible of the gene, to make it as functional as possible. Combining the best stem cell to regenerate skeletal muscle with the optimal dystrophin gene will pave the way for clinical trials to treat DMD.</gtr:abstractText><gtr:technicalSummary>Genetic correction of autologous stem cells is a potential therapy for Duchenne muscular dystrophy (DMD). However, key questions need to be resolved before this approach could be realistically used in DMD. These include the determination of the best stem cell and a safe lentivirus containing a dystrophin gene that is small enough to fit into the vector, yet large enough to code for a functional protein. We aim to design a safe lentiviral vector, coding for an effective dystrophin gene (opti-dystrophin). In parallel, we will compare the ability of induced pluripotent stem cells (iPS) and adult stem cells (AC133+ cells), firstly of mouse origin and then of human origin, to efficiently regenerate skeletal muscle and functionally reconstitute the satellite cell (muscle stem cell) pool following intra-arterial injection in an immunodeficient mouse model of DMD. We will then combine the optimised lentivirus with the most favourable stem cell of DMD origin and test this in our in vivo model. Solving these preclinical questions will allow us to plan for future clinical trials for DMD.</gtr:technicalSummary><gtr:fund><gtr:end>2014-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1215168</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>4th Annual Conference MRC Centre for Neuromuscular Diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8527C70D-7A03-4BD6-87BF-A1348C9A741C</gtr:id><gtr:impact>Approximately 300 researchers attended this event in Newcastle Upon Tyne. Presentation was entitled &amp;quot;Mini-Dystrophin Constructs for Gene Delivery to Skeletal Muscle; Project overview and preliminary results&amp;quot;.

Opportunity to discuss current research with researchers working in the field.</gtr:impact><gtr:outcomeId>taaByqS79wv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3rd Annual Conference MRC Centre for Neuromuscular Diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC31DB42-8A4A-4755-B5FC-D46C7FCEF75C</gtr:id><gtr:impact>Attended by approximately 300 researchers. Conference held in the Dubowitz Neuromuscular Centre, Institute of Child Health, London. Poster entitled &amp;quot;Optimal Mini-Dystrophin Construct for Gene Delivery to Skeletal Muscle: Project overview and preliminary results&amp;quot;.

An opportunity to discuss progress with prominent researchers working in the field.</gtr:impact><gtr:outcomeId>bTApMSPgfSt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The 10th Annual Conference of the British Society for Gene and Cell Therapy, Royal Holloway, University of London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC49507D-F03C-49B1-BB3E-ACDAC500F28B</gtr:id><gtr:impact>17-19 April 2013. The 10th Annual Conference of the British Society for Gene and Cell Therapy, Royal Holloway, University of London. &amp;quot;Jinhong Meng, Rowan Asfahani, Soyon Chun, Francesco Muntoni and Jennifer E. Morgan. Human skeletal muscle-derived AC133+ cells form functional muscle stem cells after intramuscular transplantation into immunodeficient host mice&amp;quot;

none.</gtr:impact><gtr:outcomeId>cttWsqCiNVB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Neuromuscular Translational Research Conference 2013, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4578C334-1D5A-4BFC-80AE-A012C90E8FF3</gtr:id><gtr:impact>14th - 15th March, 2013. UK Neuromuscular Translational Research Conference 2013, Oxford. &amp;quot;Jinhong Meng, Rowan Asfahani, Soyon Chun, Francesco Muntoni and Jennifer E. Morgan. Human skeletal muscle-derived AC133+ cells form functional muscle stem cells after intramuscular transplantation into immunodeficient host mice&amp;quot;

none</gtr:impact><gtr:outcomeId>jzkFvHMBrEA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PhD-student research day; Institute of Genetic Medicine, International Centre for Life, Newcastle University</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3A171997-4FBB-4007-B7E1-BC6F72D66BC6</gtr:id><gtr:impact>January 2013: PhD-student research day; Institute of Genetic Medicine, International Centre for Life, Newcastle University
Optimal dystrophin construct for gene delivery to skeletal muscle
Poster presentation by Mojgan Reza

none</gtr:impact><gtr:outcomeId>ioZqp6vHMdy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Action Duchenne Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A65072F4-7EA2-4A2E-9B5F-95ADA32F5817</gtr:id><gtr:impact>Approximately 200 parents attended this conference and asked questions following the presentation

Nothing at this stage but it is likely that an update on this research will be given at the next annual conference</gtr:impact><gtr:outcomeId>Eof8p39FfdZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The 10th Annual Conference of the British Society for Gene and Cell Therapy, Royal Holloway, University of London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>03862D04-AD0C-4985-9DE5-F282EDF90E7D</gtr:id><gtr:impact>Poster presentation: Development of a recombinogenic lentivirus for the transfer of Human Dystrophin cDNA to DMD stem cells
Authors: John Counsell, Veronica Ferrer, Jinhong Meng, Francesco Muntoni, Jennifer E Morgan, and Olivier Danos


none</gtr:impact><gtr:outcomeId>roA62T48jSS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>18th International Congress of the World Muscle Society; Pacific Grove, California, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0FBAF59F-342B-4AD9-9FBC-C674A4EB8C7A</gtr:id><gtr:impact>18th International Congress of the World Muscle Society; Pacific Grove, California, USA
October 2013
Optimised dystrophin mini-constructs for gene delivery to skeletal muscle


Fellowship award for the submitted abstract for poster presentation at the 18th International Congress of the World Muscle Society; Pacific Grove, California, USA - awarded to Mojgan Reza</gtr:impact><gtr:outcomeId>mAtXQH1crG2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Action Duchenne Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ED34EF30-3398-4B0F-B023-863EBF48E5D2</gtr:id><gtr:impact>Annual conference for those affected by Duchenne Muscular Dystrophy and attended by approximately 200 people. Presentation was entitled &amp;quot;Stem cells for Duchenne Muscular Dystrophy&amp;quot;. Location was the Holiday Inn, Bloomsbury, London. Good engagement from the audience.

Invited again in 2012 given the interest from parents in stem cell related research for Duchenne Muscular Dystrophy.</gtr:impact><gtr:outcomeId>j6y34XQQhnB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute seminar; Institute of Genetic Medicine, International Centre for Life, Newcastle University</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8E0B52C3-C82D-49C7-AFFE-B2144D3607B4</gtr:id><gtr:impact>June 2013: Institute seminar; Institute of Genetic Medicine, International Centre for Life, Newcastle University
Optimised dystrophin mini-constructs for gene delivery to skeletal muscle
Talk by Mojgan Reza

None</gtr:impact><gtr:outcomeId>CmnfvE5G3cX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>559676</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust University Award (The role of stem and progenitor cell populations in skeletal muscle homeostasis, repair and regeneration)</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>8F9E7282-40DE-4107-92D9-184C7822A7D3</gtr:id><gtr:outcomeId>B3523F5757B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>666193</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J005436/1</gtr:fundingRef><gtr:id>842CD53A-23A4-40ED-B0BB-6460F9D8E738</gtr:id><gtr:outcomeId>s9f1RHzvuGc</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>36292</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Child Health Research Appeal Trust</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Child Health Research Appeal Trust (CHRAT)</gtr:fundingOrg><gtr:fundingRef>2011 PhD-03</gtr:fundingRef><gtr:id>7A36DF2B-C0F5-4ED9-BDA5-3BB1991BCCFB</gtr:id><gtr:outcomeId>j36sxBkshSu</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1215190</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Translational Stem Cell Research Committee (TSCRC) Grant</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9D692BF6-E8FF-479E-9B55-1A20C1F1846C</gtr:id><gtr:outcomeId>4F9B9D8C5DD0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:fundingRef>16280</gtr:fundingRef><gtr:id>B9C8D796-3676-44D7-ABE9-141FB25020CB</gtr:id><gtr:outcomeId>CCn3mLNLPgB</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228275</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Muscular Dystrophy Campaign</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>739E4E42-02A1-4043-B4D6-51C9AC0395C8</gtr:id><gtr:outcomeId>FE621FD6B5D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18521</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Association Fran&amp;ccedil;aise contre les myopathies</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:fundingRef>16820</gtr:fundingRef><gtr:id>5D7A6C17-B99E-47F0-BBF9-361086B99473</gtr:id><gtr:outcomeId>F2WUtywAJhi</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>116126</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research leadership</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Great Ormond Street Hospital Children's Charity (GOSHCC)</gtr:fundingOrg><gtr:fundingRef>V1300</gtr:fundingRef><gtr:id>AF83BB78-9E51-434C-917F-B5F25513CB9A</gtr:id><gtr:outcomeId>DcLYDvRSTng</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>21230</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Validation of Serum Biomarkers for DMD</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>French Muscular Dystrophy Association (AFM)</gtr:fundingOrg><gtr:id>DF27E347-36FB-4DDC-A53E-94D5CA7AD58D</gtr:id><gtr:outcomeId>56d82d5e4ca599.73290058</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Building the Knowledge Base for Therapy Development in Duchenne Muscular Dystrophy</gtr:description><gtr:end>2020-06-02</gtr:end><gtr:fundingOrg>Action Duchenne</gtr:fundingOrg><gtr:id>485A1B16-1185-4EAC-B342-EF4A2A969771</gtr:id><gtr:outcomeId>56d82dc14c6405.69487706</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>60869213-BD67-42A5-A4CE-76DE4CBF09A6</gtr:id><gtr:title>Delivery of large transgene cassettes by foamy virus vector.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fdb407de380fe4d6dfda8cafaaa3024"><gtr:id>7fdb407de380fe4d6dfda8cafaaa3024</gtr:id><gtr:otherNames>Sweeney NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a35e3db79dbf0.20456511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03BD91E7-4877-4969-B386-4F5F9610BA8D</gtr:id><gtr:title>Stem cells to treat muscular dystrophies - where are we?</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_13484_24_21055938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CB9D669-9199-435C-96A4-40C758EF6C0F</gtr:id><gtr:title>Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>CB8A25CA_8CB8A25CA_8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F1CE6AD-274C-4282-90EC-0CCAFB607D41</gtr:id><gtr:title>Lentiviral vectors can be used for full-length dystrophin gene therapy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8285b708ad4a42037c271ee593f4e236"><gtr:id>8285b708ad4a42037c271ee593f4e236</gtr:id><gtr:otherNames>Counsell JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bd7029982096.70510532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F389B653-E3A2-451C-ABE0-7D5730571639</gtr:id><gtr:title>Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d03edb0678e5.87205456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADEA40D3-454C-4AE7-B680-F6845D796835</gtr:id><gtr:title>A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10b0e14580417ba1cfb9d1c5b3767efe"><gtr:id>10b0e14580417ba1cfb9d1c5b3767efe</gtr:id><gtr:otherNames>Estephan EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5a995f870b2e24.96192015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9D74B93-2B04-448D-AABA-62E8C5444D1F</gtr:id><gtr:title>Mouse regenerating myofibers detected as false-positive donor myofibers with anti-human spectrin.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8457cdf0b8e97c1e66478931df0aa55e"><gtr:id>8457cdf0b8e97c1e66478931df0aa55e</gtr:id><gtr:otherNames>Rozkalne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>544e5533d85bd6.38858247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1DE0B4C-AF3D-49AB-89DA-567356D6C3A6</gtr:id><gtr:title>The human desmin promoter drives robust gene expression for skeletal muscle stem cell-mediated gene therapy.</gtr:title><gtr:parentPublicationTitle>Current gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9169c43665936aad66d211d45a2743a9"><gtr:id>9169c43665936aad66d211d45a2743a9</gtr:id><gtr:otherNames>Jonuschies J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1566-5232</gtr:issn><gtr:outcomeId>544e5355d072c2.60293585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB72ABD7-507D-491D-AB38-FBF9D1E27481</gtr:id><gtr:title>The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells.</gtr:title><gtr:parentPublicationTitle>Skeletal muscle</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-5040</gtr:issn><gtr:outcomeId>56d03f259c36b7.05372362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E77FFB9A-4DCA-4D6D-8058-0683877E522E</gtr:id><gtr:title>Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e84e3707839d90302345838b73f672b7"><gtr:id>e84e3707839d90302345838b73f672b7</gtr:id><gtr:otherNames>Meng J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>544e5355911865.98546721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38675E7E-6D1D-48BE-A6DB-8B3A6A049DDF</gtr:id><gtr:title>MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7510162e96297e5cda1dc964e260b5c3"><gtr:id>7510162e96297e5cda1dc964e260b5c3</gtr:id><gtr:otherNames>Reza M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>5a2fd3740ce042.44419083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2707B858-53B8-440C-AF1A-25398E0685D6</gtr:id><gtr:title>Optimization of Internally Deleted Dystrophin Constructs.</gtr:title><gtr:parentPublicationTitle>Human gene therapy methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7510162e96297e5cda1dc964e260b5c3"><gtr:id>7510162e96297e5cda1dc964e260b5c3</gtr:id><gtr:otherNames>Reza M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6536</gtr:issn><gtr:outcomeId>58bd709a8a2ab9.86086039</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900872</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>